Patent: 8,785,400
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Summary for Patent: 8,785,400
Title: | Methods and compositions relating to islet cell neogenesis |
Abstract: | The present invention provides methods and kits for treating diseases and conditions associated with impaired pancreatic function. The present invention further provides methods of stimulating islet cell neogenesis and stimulating islet cell differentiation from progenitor cells. |
Inventor(s): | Levetan; Claresa S. (Rosemont, PA), Upham; Loraine V. (Albuquerque, NM) |
Assignee: | CureDM Group Holdings, LLC (Wilmington, DE) |
Application Number: | 11/943,991 |
Patent Claims: | see list of patent claims |
Details for Patent 8,785,400
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Sign Up | 2026-11-22 |
Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | 02/19/2002 | ⤷ Sign Up | 2026-11-22 |
Hoffmann-la Roche Inc. | ZENAPAX | daclizumab | Injection | 103749 | 12/10/1997 | ⤷ Sign Up | 2026-11-22 |
Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 05/07/2001 | ⤷ Sign Up | 2026-11-22 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |